Health

Providers are voicing concern over HHS Secretary Robert F. Kennedy Jr.’s firing of the vice chairs of the U.S. Preventive Services Task Force (USPSTF). They say the move raises fresh …

After disrupting the prescription drug market with Cost Plus Drugs — which now has the White House seal of approval — Mark Cuban has quietly turned to the employer market. Since …

Healthcare revenue cycle management (RCM) sits at an inflection point. Advances in AI are expanding what is possible across healthcare, with generative models expected to drive meaningful productivity gains.  That …

While conversations around GLP-1s typically center on adults, a new report sheds light on prescribing trends among adolescents and offers recommendations for how employers can manage coverage and care. The …

Two large, international healthcare investment firms announced their plans to merge on Wednesday.  The partners — London-based GHO Capital and Singapore-based CBC Group — said the deal will combine $21 …

Engineered viruses are a mainstay in genetic medicine due to their ability to ferry genetic cargo into cells. But limitations of this approach have sparked research into methods that don’t …

Tennessee has taken a meaningful step toward restoring trust in the prescription drug marketplace. With the passage of Senate Bill 2040 and Governor Bill Lee expected to sign it into …

A new healthcare-focused investment firm launched on Tuesday with support from Nueterra Capital. It’s seeking to help startups navigate the jump from product validation to true commercial scale. The firm, …

Nourish, a metabolic health clinic, announced Tuesday that it raised $100 million in Series C funding, which will help grow its clinical network. New York City-based Nourish has more than …

A BioMarin Pharmaceutical deal last year brought the company a late-stage therapy that fit the company’s extensive enzyme replacement experience while also offering the potential to become the first treatment …